Showing 1 - 6 results of 6 for search 'Jérémie Decalf', query time: 0.04s Refine Results
  1. 1
    Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy.

    Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy. by Eric G Meissner, Jérémie Decalf, Armanda Casrouge, Henry Masur, Shyam Kottilil, Matthew L Albert, Darragh Duffy

    Published 2015-01-01
    Get full text
    Article
  2. 2
    Dynamics of HIV-containing compartments in macrophages reveal sequestration of virions and transient surface connections.

    Dynamics of HIV-containing compartments in macrophages reveal sequestration of virions and transient surface connections. by Raphaël Gaudin, Stefano Berre, Bruna Cunha de Alencar, Jérémie Decalf, Michael Schindler, François-Xavier Gobert, Mabel Jouve, Philippe Benaroch

    Published 2013-01-01
    Get full text
    Article
  3. 3
    1050 Human stem cell derived dendritic cells provide a physiologically relevant system to evaluate the pharmacology of a FLT3L-Fc fusion protein for cancer immunotherapy

    1050 Human stem cell derived dendritic cells provide a physiologically relevant system to evaluate the pharmacology of a FLT3L-Fc fusion protein for cancer immunotherapy by Christine Moussion, Dongping He, Anaïs Duval, Sarah Exbrayat, Meredith McLerie, Matthew Betzenhauser, Jérémie Decalf, Travis W Bainbridge, Christopher Kemball

    Published 2023-11-01
    Article
  4. 4
    Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post‐translational modification: prospective placebo‐controlled clinical studies

    Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post‐translational modification: prospective placebo‐controlled clinical studies by Jérémie Decalf, Kristin V Tarbell, Armanda Casrouge, Jeffrey D Price, Grace Linder, Estelle Mottez, Philippe Sultanik, Vincent Mallet, Stanislas Pol, Darragh Duffy, Matthew L Albert

    Published 2016-04-01
    Get full text
    Article
  5. 5
    A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc Molecule

    A Minimal PBPK/PD Model with Expansion-Enhanced Target-Mediated Drug Disposition to Support a First-in-Human Clinical Study Design for a FLT3L-Fc Molecule by Iraj Hosseini, Brett Fleisher, Jennifer Getz, Jérémie Decalf, Mandy Kwong, Meric Ovacik, Travis W. Bainbridge, Christine Moussion, Gautham K. Rao, Kapil Gadkar, Amrita V. Kamath, Saroja Ramanujan

    Published 2024-05-01
    Get full text
    Article
  6. 6
    A single point mutation on FLT3L-Fc protein increases the risk of immunogenicity

    A single point mutation on FLT3L-Fc protein increases the risk of immunogenicity by Dan Qin, Qui Phung, Patrick Wu, Zhaojun Yin, Sien Tam, Peter Tran, Adel M. ElSohly, Joshua Gober, Zicheng Hu, Zhenru Zhou, Sivan Cohen, Dongping He, Travis W. Bainbridge, Christopher C. Kemball, Jonathan Zarzar, Alavattam Sreedhara, Nicole Stephens, Jérémie Decalf, Christine Moussion, Zhengmao Ye, Mercedesz Balazs, Yinyin Li

    Published 2025-02-01
    Get full text
    Article

Search Tools: